Stanford Medicine
Leadership Retreat

RECLAIMING HEALTH IN 2021

May 21, 2021 | 1:00 – 5:00 pm PT

JOIN NOW

The COVID-19 pandemic changed life as we know it in 2020, yet this year will prove even more consequential.
Decisions today will decide health care’s future for decades to come. At a time that demands interdisciplinary collaboration, innovative approaches, and cutting-edge science, Stanford Medicine is poised to lead a better, more equitable, and preventive health care system.

1:00 – 1:25 pm | Welcome and Introduction

1:25 – 2:00 pm | Preparing for an Uncertain Future

2:00 – 2:30 pm | Basic Science Spotlights
2:30 – 2:40 pm | Break
2:40 – 3:10 pm | Update on Commission on Justice and Equity

3:10 – 3:55 pm | Available Online & In-Store: Health Care’s New Setting

3:55 – 4:05 pm | Break
4:05 – 4:50 pm | What Happens Next – How We Build Back Stronger After a Global Pandemic
4:50 pm | Closing Remarks
4:55 pm | Program Ends

AGENDA

1:00 – 1:25 pm

Welcome and Introduction

Lloyd Minor

Lloyd Minor, Dean, Stanford School of Medicine | BIO

David Entwistle

David Entwistle, President and CEO, Stanford Health Care | BIO

Paul King

Paul King, President and CEO, Stanford Children’s Health | BIO

1:25 – 2:00 pm 

Preparing for an Uncertain Future

Amid a global pandemic, the future has never been murkier – or filled with more opportunity. In a fireside chat with Dean Lloyd Minor, Regina Dugan will reflect on her career – including leadership roles as the former Director of DARPA and VP of Engineering-Advanced Technology and Projects at Google – discuss how hardship has historically driven transformative change, and share keys for catalyzing a movement that meets this moment.

Lloyd Minor

Lloyd Minor, Dean, Stanford School of Medicine | BIO

Regina Dugan

Regina Dugan, President and CEO, Wellcome Leap | BIO

2:00 – 2:30 pm

Basic Science Spotlights

Basic science underpins Stanford Medicine’s preeminence. In this session, four basic scientists will highlight their innovative research – a sampling of the groundbreaking work occurring in labs across Stanford Medicine.

Hijacking Blood Cells to Deliver Therapies: A Novel Platform for Neurodegeneration

Natalia Gomez-Ospina

Natalia Gomez-Ospina, Assistant Professor of Pediatrics (Genetics) and of Pediatrics
(Stem Cell Transplantation), Stanford School of Medicine | BIO

Using High-Throughput Polled CRISPR Screens to Identify New Cancer Drug Targets and Drug Combinations

Michael Bassik

Michael Bassik, Associate Professor of Genetics,
Stanford School of Medicine | BIO

The Stanford Hospital Microbiome Observatory – Leveraging the Power of Microbes to Cure and Prevent Diseases

Ami Bhatt

Ami Bhatt, Associate Professor of Medicine (Hematology) and of Genetics,
Stanford School of Medicine | BIO

Patient Earth: A New School of Medicine Mission

Ellen Yeh

Ellen Yeh, Associate Professor of Pathology and of Microbiology and Immunology,
Stanford School of Medicine | BIO

2:30 – 2:40 pm

Break

2:40 – 3:10 pm

Update on Commission on Justice and Equity

Formed in the wake of George Floyd’s murder and other horrific instances of social injustice, the Commission on Justice and Equity has set out to identify how Stanford Medicine can strengthen diversity, equity, and inclusion practices and assert a national role in addressing health disparities. This update will share insights gleaned from interviewing the Stanford Medicine community and their recommendations for moving forward.

Rosalind Hudnell

Rosalind Hudnell, Former VP, Global Corporate Affairs, Intel and President,
Intel Foundation | BIO

Terrance Mayes

Terrance Mayes, Associate Dean for Equity and Strategic Initiatives, and Executive Director
of Commission on Justice and Equity, Stanford School of Medicine | BIO

3:10 – 3:55 pm

Available Online & In-Store: Health Care’s new setting

For all the unpredictability of the past year, one thing is certain: “Where health care happens” has forever changed. The pandemic spurred record investment in digital health in 2020 as well as numerous initiatives by national retailers to make care more accessible for millions of people. This panel will discuss how biomedicine is poised for transformation as health care’s setting expands beyond traditional boundaries.

Panelists:

Annie Lamont

Annie Lamont, Co-founder and Managing Partner, Oak HC/FT | BIO

Tom Mcguinness

Tom McGuinness, Corporate VP, Global Healthcare, Microsoft | BIO

Thomas Van Gilder

Thomas Van Gilder, Chief Medical Officer, Walmart | BIO

Moderator:

Carla Pugh

Carla Pugh, Professor of Surgery, Stanford School of Medicine | BIO

3:55 – 4:05 pm

Break

4:05 – 4:50 pm

What Happens Next – How We Build Back Stronger After a Global Pandemic

Our national COVID-19 response has catalyzed collaboration—among local governments, health organizations, and research institutions—on an unprecedented scale and to extraordinary effect. As we prepare for a post-pandemic future, we must resist returning to siloes and further cultivate collaboration to ensure that we build back stronger.

Panelists:

Amy Abernethy

Amy Abernethy, Former Principal Deputy Commissioner, FDA | BIO

Alyce Adams

Alyce Adams, Professor of Epidemiology and Population Health,
Stanford School of Medicine | BIO

Aaron Gitler

Aaron Gitler, Professor of Genetics, Stanford School of Medicine | BIO

Bob Kocher

Bob Kocher, Partner, Venrock; Former Special Assistant to the President,
Healthcare and Economic Policy | BIO

Moderator:

Bob Harrington

Bob Harrington, Professor of Medicine and Chair of the Department of Medicine,
Stanford School of Medicine | BIO

4:50 pm

Closing Remarks

Lloyd Minor

Lloyd Minor, Dean, Stanford School of Medicine | BIO

4:55 pm

Program ends

(DoorDash dinner vouchers to be provided)

FAQs

What if the "Join Live Button" isn't working?

The button will be activated at 12:30 pm PT on Friday, May 21st. If you visit the website before 12:30 pm, please refresh your browser and re-try the “Join Live Now” button. If this does not work, please use the Tech Support Chat on this website or email Marilena McCarty (mccartym@stanford.edu).

How can I make sure my computer is compatible to view the program?

To optimize your virtual experience, please make sure you have the most updated version of Zoom installed. 
https://zoom.us/download

Where can I find my DoorDash voucher?

A link to a DoorDash voucher was sent in a communication from the Office of the Dean on May 17 and will be resent the morning of the retreat. Email Kelly Tsutsumi (kelly.tsutsumi@stanford.edu) if you are unable to locate your voucher.

WHAT HAPPENS IF I HAVE TECHNICAL DIFFICULTIES?

If you are having technical difficulties, please use the Tech Support Chat on this website or email Marilena McCarty (mccartym@stanford.edu).

CAN I PASS ON THE INVITATION TO A COLLEAGUE?

This is an invitation-only event. Please contact Kelly Tsutsumi (kellytsu@stanford.edu) if you have any requests or questions.

SHOULD MY AUDIO AND VIDEO BE ON DURING THE PROGRAM?

We encourage you to enable your video. You will be able to unmute yourselves during open sessions.

Copyright © 2021 Stanford Medicine. All Rights Reserved.

Legal | Privacy | Code of Conduct | Notice of Nondiscrimination

Event Experience Production: CXFormula, LLC
Aaron Gitler

Aaron Gitler

Professor of Genetics,
Stanford School of Medicine

Aaron Gitler, PhD, focuses his research on the cell biology underpinning protein-misfolding diseases such as Parkinson’s, Alzheimer’s, and ALS, or Lou Gehrig’s disease. Protein folding is critically important for all life, from microbes to man. A bafflingly diverse set of cellular mechanisms has evolved to coordinate this process. Not unexpectedly, problems in protein folding are the root cause of many of the most devastating diseases, which represent a major challenge to public health worldwide, especially as our population continues to age. He is a member of Stanford Bio-X and Wu Tsai Neurosciences Institute.

Annie Lamont

Annie Lamont

Co-founder and Managing Partner, Oak HC/FT

Annie Lamont is a Co-Founder and Managing Partner of Oak HC/FT, where she focuses on growth equity and early-stage venture opportunities in health care and financial technology. Lamont serves on the boards of Advise Health Holdings, Brightline, CareBridge, Independent Living Systems, Oncology Analytics, OODA Health, Precision Medicine Group, Quartet, Rubicon Founders, Truepill, Vesta Health, and VillageMD. She is a member of the Stanford Medicine Board of Fellows and is a former member of the Stanford University Board of Trustees. Lamont has appeared on the Forbes Midas List, Institutional Investor’s FinTech Finance 40 list, and the Top 100 Venture Capitalist rankings published by CB Insights and The New York Times. Lamont was also honored with Healthcare Private Equity Association’s 2017 Russell L. Carson Award for lifetime achievement in health care investing. She serves as a core participant of the Health and Human Services Deputy Secretary’s Innovation and Investment Summit.

Paul King

Paul King

President and CEO,
Stanford Children’s Health

Paul A. King joined Stanford Children’s Health in January 2019. King’s distinguished, 30-plus year career as a health care executive includes leadership positions at several nationally recognized academic medical centers. Prior to joining Stanford Children’s Health, King led the University of Michigan’s C.S. Mott Children’s Hospital and Von Voigtlander Women’s Hospital as Executive Director. During his tenure, he guided the strategic growth of the University of Michigan’s children’s and women’s programs and services. Prior to joining C.S. Mott Children’s Hospital, King served as President and CEO for the Pediatric Management Group, a 550-physician academic pediatric subspecialty group practice affiliated with Children’s Hospital Los Angeles. His strong leadership record also includes senior management roles at the Mayo Clinic and the Samaritan Physicians Center.

Lloyd Minor

Lloyd Minor

Dean,
Stanford School of Medicine

Lloyd B. Minor, MD, is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine. With his leadership, Stanford Medicine has established a strategic vision to lead the biomedical revolution in Precision Health, a fundamental shift to more proactive and personalized health care that empowers people to lead healthy lives. His book, “Discovering Precision Health,” published in 2020, highlights how biomedical advances are dramatically improving our ability to treat and cure complex diseases. Minor also is a Professor of Otolaryngology–Head and Neck Surgery and a Professor of Bioengineering and of Neurobiology, by courtesy, at Stanford University. With more than 160 published articles and chapters, Minor is an expert in balance and inner ear disorders. In 2012, he was elected to the National Academy of Medicine.

Bob Harrington

Professor of Medicine and Chair of the Department of Medicine, Stanford School of Medicine

Robert A. Harrington, MD, is a cardiologist and the Arthur L. Bloomfield Professor of Medicine and Chair of the Department of Medicine at Stanford. His research interests include evaluating antithrombotic therapies to treat acute ischemic heart disease and to minimize the acute complications of percutaneous coronary procedures, studying the mechanism of disease of the acute coronary syndromes, and understanding the issue of risk stratification in the care of patients with acute ischemic coronary syndromes. He is actively building local, national and international collaborations for the efficient conduct of innovative clinical research and trying to better understand and improve upon the methodology of clinical research. Harrington’s research has been extensively funded through NIH, NIA, other peer-reviewed agencies and private industry. He is an elected member of the Association of American Physicians, the Association of University Cardiologists and the National Academy of Medicine. During 2019-2020, he served as President of the American Heart Association.

Rosalind Hudnell

Rosalind Hudnell

Former VP, Global Corporate Affairs, Intel and President, Intel Foundation

Rosalind (Roz) L. Hudnell is former Vice President in Human Resources, Director of Corporate Affairs at Intel Corporation, and former President of the Intel Foundation. In this role, she oversaw professionals in more than 35 countries working to enhance Intel’s reputation as the world’s leading technology brand and corporate citizen. A 22-year Intel veteran, Hudnell joined Intel as a public affairs manager and has held various leadership positions in community relations, government relations, foundation, media outreach, employee volunteerism, and human resources. Most recently, Hudnell was Chief Diversity Officer and helped to launch Intel’s Diversity in Technology initiative, a multiyear $1 billion investment effort to accelerate diversity and inclusion across the technology industry at large. Hudnell led the development of the 10k Engineer’s Initiative for President Obama’s U.S. Council on Jobs and Competitiveness and served as a consultant to the development of the documentary film Girl Rising. Hudnell is also widely known for directing the implementation of the Intel Computer Clubhouse Network, a global, award-winning program bringing leading-edge technology to underserved youth around the world.

Terrance Mayes

Associate Dean for Equity and Strategic Initiatives, and Executive Director of Commission on Justice and Equity,
Stanford School of Medicine

Terrance Mayes, PhD, a nationally recognized higher education leader, serves as the inaugural Associate Dean for Equity and Strategic Initiatives and the Executive Director of the Commission on Justice and Equity at Stanford Medicine. In this role, Mayes is a key strategy leader for equity, diversity, and inclusion efforts across the Stanford Medicine enterprise. During his career, Mayes has mentored and supported thousands of diverse individuals to pursue education and careers in STEM, health care, and academia. He has also delivered hundreds of lectures around the country, making the case that supporting diversity, practicing inclusion, and expecting equity is critical to the future of higher education and our broader society.

Regina Dugan

Regina Dugan

President and CEO, Wellcome Leap

Regina E. Dugan, PhD, is an internationally recognized business executive, producer, engineer-artist, taskmaster, and product developer. She is currently Chief Executive Officer at Wellcome Leap, where she is driving bold, unconventional programs to deliver breakthroughs in human health. She has led world-class global teams, and hundred-million to multi-billion dollar efforts to deliver breakthrough products at Facebook, Google, Motorola, and as the 19th Director and first woman to lead the Defense Advanced Research Projects Agency (DARPA).

FORTUNE described Dugan as one of the world’s leading experts on product innovation, “the kind that unhinges old ways of operating, juices competition and creates new growth.” She has been named to the Verge 50 list, Fast Company’s ‘Most Creative People in Business 1000,’ CNN’s ‘Top 10 Thinkers,’ and CNBC’s ‘NEXT LIST.’ As executive producer, she has 4 Annie Awards, 1 Emmy, and 1 OSCAR nomination.

Tom Mcguinness

Tom McGuinness

Corporate VP, Global Healthcare, Microsoft

Tom McGuinness is responsible for leading the development and execution of Microsoft’s health care strategy and go-to-market, supporting health care customers in their digital transformation journeys. Prior to joining Microsoft in April 2020, McGuinness was the President & CEO of GE Healthcare’s $10 billion Imaging franchise. Prior to GE, he led two other health care businesses: as Vice President and General Manager of Medtronic’s global Biologics business and as CEO of PatientPoint. He began his career with McKinsey & Company where he was a partner and a leader in their health care practice. He participates on several boards, including AdvaMed (med tech’s industry association), World Business Chicago, Chicago’s Museum of Science & Industry, and McKinsey’s Alumni Leaders Council.

Alyce Adams

Alyce Adams

Professor of Epidemiology and Population Health, Stanford School of Medicine

Alyce Adams, PhD, is the inaugural Stanford Medicine Innovation Professor and Professor of Epidemiology and Population Health and of Medicine (Primary Care and Outcomes Research), as well as Director for Community Outreach and Engagement in the Stanford Cancer Institute. Focusing on racial and socioeconomic disparities in chronic disease treatment outcomes,  Adams’ interdisciplinary research seeks to evaluate the impact of changes in drug coverage policy on access to essential medications, understand the drivers of disparities in treatment adherence among insured populations, and test strategies for maximizing the benefits of treatment outcomes while minimizing harms through informed decision-making. Prior to joining Stanford, Adams was Associate Director for Health Care Delivery and Policy and a Research Scientist at the Kaiser Permanente Division of Research, as well as a Professor at the Bernard J. Tyson Kaiser Permanente School of Medicine. From 2000 to 2008, she was an Assistant Professor in the Department of Population Medicine (formerly Ambulatory Care and Prevention) at Harvard Medical School and Harvard Pilgrim Health care.

Michael Bassik

Michael Bassik

Associate Professor of Genetics,
Stanford School of Medicine

Michael Bassik, PhD, and his lab study how endocytic pathogens such as bacterial toxins, viruses, and protein aggregates enter the cell, disrupt homeostasis, and cause apoptosis. More broadly, they would like to understand how diverse stresses induced by biological, chemical, and therapeutic agents signal to the cell death machinery. To do this, they use basic cell biology and biochemistry, as well as novel ultra-complex shRNA libraries they have developed, which have allowed the first systematic genetic interaction maps in mammalian cells. A complementary interest is the development of technologies for screening and measuring genetic interactions, with the ultimate goal of finding synergistic drug targets for endocytic pathogens and other diseases such as cancer and Alzheimer’s.

Bob Kocher

Bob Kocher

Partner, Venrock; Former Special Assistant to the President, Healthcare and Economic Policy

Bob Kocher, MD, is a Partner at Venrock and focuses on healthcare IT and services investments. He is an Adjunct Professor at Stanford School of Medicine and a Non-Resident Senior Fellow and Advisory Board Member at the Leonard D. Schaeffer Center for Health Policy and Economics at USC. He serves on the boards of Devoted Health, Virta Health, Aledade, Lyra Health, Newco Health, Sitka, and Premera Blue Cross.  He also serves on the Advisory Board of the National Institute for Healthcare Management. Prior to Venrock, Kocher served in the Obama Administration as Special Assistant to the President for Healthcare and Economic Policy on the National Economic Council.

Amy Abernethy

Amy Abernethy

Former Principal Deputy Commissioner, FDA

Amy P. Abernethy, MD, PhD, is an internationally known oncologist, health data expert, and digital health leader. For more than 20 years, she has pioneered the development of technology platforms to spur novel advancements in clinical care, including the development of systems by which linked clinical data can support tracking cancer care, drug development, personalized medicine and scientific discovery. Most recently, Abernethy was Principal Deputy Commissioner and Acting Chief Information Officer of the U.S. Food and Drug Administration, serving from February 2019 to April 2021, where she initiated multiple critical efforts, including the agency’s technology and data modernization action plans and its efforts to leverage real-world data and evidence to address critical questions during the COVID-19 pandemic. Prior to joining the FDA, Abernethy was Chief Medical Officer and Chief Scientific Officer at Flatiron Health. Prior to that, she was Professor of Medicine at Duke University School of Medicine and directed the Center for Learning Health Care in the Duke Clinical Research Institute and Duke Cancer Care Research Program in the Duke Cancer Institute.

Carla Pugh

Carla Pugh

Professor of Surgery, Stanford School of Medicine

Carla Pugh, MD, PhD, is Professor of Surgery at Stanford University School of Medicine and the Director of the Technology Enabled Clinical Improvement Center. Her clinical area of expertise is Acute Care Surgery. As the first surgeon in the United States to obtain a PhD in Education, her goal is to use technology to change the face of medical and surgical education. Her research involves the use of simulation and advanced engineering technologies to develop new approaches for assessing and defining competency in clinical procedural skills. Pugh holds three patents on the use of sensor and data acquisition technology to measure and characterize hands-on clinical skills.

Thomas Van Gilder

Thomas Van Gilder

Chief Medical Officer, Walmart

Tom Van Gilder, MD, JD, MPH, is Chief Medical Officer at Walmart, where he is leading and developing the company’s clinical organization encompassing primary care, dental, optical, hearing, behavioral health, and pharmacy services. He also is leading a growing clinical analytics group that supports existing pharmacies and clinics as well as innovative new health offerings. Van Gilder designed and led Walmart’s response to COVID-19, from protecting associates and customers to serving communities through testing and vaccination. Prior to his role at Walmart, Van Gilder served as Chief Medical Officer and Vice President for Analytics and Informatics at Humana’s Transcend Insights, bringing together three prior acquisitions to guide the clinical and analytics portions of the new, combined company. Previously, he had been National Medical Director for Wellness at Humana. Van Gilder also served as Medical Director for Quality Initiatives at QuadMed. For more than nine years, he was a senior medical epidemiologist with the U.S. Centers for Disease Control and Prevention. Van Gilder also is an attorney specializing in intellectual property.

Ami Bhatt

Ami Bhatt

Associate Professor of Medicine (Hematology) and of Genetics, Stanford School of Medicine

In perpetual awe of how simple microbial organisms can perturb complex, multicellular organisms, Ami Bhatt, MD, PhD, has chosen to dedicate her research to inspecting, characterizing and dissecting the microbe-human interface. Nowhere is the interaction between hosts and microbes more potentially impactful than in immuno-compromised hosts and global settings where infectious and environmental exposures result in drastic and sometimes fatal health consequences. Bhatt’s group identifies problems and questions that arise in the course of routine clinical care. Often in collaboration with investigators at Stanford and beyond, the group applies modern genetic, molecular and computational techniques to seek answers to these questions, better understand host-microbe interactions and decipher how perturbation of these interactions may result in human disease phenotypes.

Bhatt is an award-winning teacher and gifted mentor. She is the Director of Global Oncology for the Stanford Center for Innovation in Global Health and is the co-founder and co-president of the non-profit organization Global Oncology. She is a member of Stanford Bio-X, Stanford ChEM-H, Stanford Cancer Institute, and the Maternal & Child Health Research Institute.

Ellen Yeh

Ellen Yeh

Associate Professor of Pathology and of Microbiology and Immunology, Stanford School of Medicine

Ellen Yeh, MD, PhD,  has a diverse scientific background. She started her research career as a biochemist investigating enzymatic mechanisms because they were fun puzzles that tickled her brain. Motivated by unmet medical need, she moved into the malaria field for her independent research program, making her a passable cell biologist, budding evolutionary biologist, and faux geneticist. Her brain still retains some knowledge about how to diagnose human infections from training in clinical microbiology (at the minimum she knows who to send samples to). Her goal for trainees is to help them become independent thinkers and learn “how to learn.” Issues Yeh is passionate about include but are definitely not limited to: the value of equity and diversity in science for all stakeholders, creating a community of “we” in science, effective leadership/management styles for creative teams, global health and unmet medical need in resource- and research-poor areas, and non-model organism (weird) biology.

She is a member of Stanford Bio-X, Stanford ChEM-H, and the Maternal & Child Health Research Institute.

Natalia Gomez-Ospina

Natalia Gomez-Ospina

Assistant Professor of Pediatrics (Genetics) and of Pediatrics (Stem Cell Transplantation),
Stanford School of Medicine

Natalia Gomez-Ospina, MD, PhD, is a physician scientist and medical geneticist with a strong interest in the diagnosis and management of genetic diseases. Her research is focused on developing better therapies, specifically genome editing of hematopoietic stem cells, for a large class of neurodegenerative diseases in children known as lysomal storage disorders. She was born and raised in Medellin, Colombia. She began her undergraduate studies in petroleum engineering at the Universidad Nacional de Colombia before moving to Colorado. She double majored at the University of Colorado Boulder, completing her bachelor’s degree in Molecular Cellular and Developmental Biology as well as Biochemistry. She completed her combined MD-PhD at Stanford.

David Entwistle

David Entwistle

President and CEO,
Stanford Health Care

David Entwistle is President and CEO of Stanford Health Care, where he has served since 2016. Among other achievements, Entwistle has championed the development and implementation of an integrated strategic plan that aligns Stanford Health Care, the Stanford School of Medicine, and Stanford Children’s Health behind a common vision and key strategic initiatives through 2025. Under his leadership, Stanford Health Care also has received a number of national accolades, including being named a Top 10 U.S. academic medical center for care quality by Vizient. Most recently, Entwistle spearheaded the completion of the new Stanford Hospital, which opened to patients in November 2019, representing the culmination of more than a decade of planning, design, and construction.